Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: Pooled Results From Phase 3 Trials (DERMIS-1 and DERMIS-2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s57, 2022. DOI: 10.25251/skin.6.supp.57. Disponível em: https://skin.dermsquared.com/skin/article/view/1812. Acesso em: 17 apr. 2026.